Joseph Chen

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Clinical pharmacology and therapeutics

Clinical pharmacokinetics

Nature medicine

Clinical and translational science

Pfizer Inc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pfizer Inc May 01 2016

United States

Clinical Pharmacologist/Manager :: Global Product Development

Publications

Sihem Ait-Oudhia, Joseph Chen, Junyi Li, Piet H van der Graaf
Subcutaneous Biologics: Clinical Pharmacology and Drug Development. Clinical pharmacology and therapeutics 115 (3) (2024)
Mohamed Elmeliegy, Joseph Chen, Aruna Dontabhaktuni, Allison Gaudy, Georgi I Kapitanov, Junyi Li, Sabiha R Mim, Sharad Sharma, Qin Sun, Sihem Ait-Oudhia
Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology. Clinical pharmacology and therapeutics (2024)
Mohamed Elmeliegy, Joseph Chen, Aruna Dontabhaktuni, Allison Gaudy, Georgi I Kapitanov, Junyi Li, Sabiha R Mim, Sharad Sharma, Qin Sun, Sihem Ait-Oudhia
Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T-Cell Engagers Development in Oncology. Clinical pharmacology and therapeutics 116 (3) (2024)
Sihem Ait-Oudhia, Joseph Chen, Junyi Li, Piet H van der Graaf
Subcutaneous Biologics: Clinical Pharmacology and Drug Development. Clinical pharmacology and therapeutics 115 (3) (2024)
Kelly C Goldsmith, Julie R Park, Kimberly Kayser, Jemily Malvar, Yueh-Yun Chi, Susan G Groshen, Judith G Villablanca, Kateryna Krytska, Lillian M Lai, Patricia T Acharya, Fariba Goodarzian, Bruce Pawel, Hiroyuki Shimada, Susan Ghazarian, Lisa States, Lynley Marshall, Louis Chesler, Meaghan Granger, Ami V Desai, Rajen Mody, Daniel A Morgenstern, Suzanne Shusterman, Margaret E Macy, Navin R Pinto, Gudrun Schleiermacher, Kieuhoa Vo, Holger C Thurm, Joseph Chen, Marlon Liyanage, Gerson Peltz, Katherine K Matthay, Esther R Berko, John M Maris, Araz Marachelian, Yael P Mosse
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nature medicine (2023)
Sherry M Ibrahim, Yazdi K Pithavala, Manoli Vourvahis, Joseph Chen
A literature review of liver function test elevations in rifampin drug-drug interaction studies. Clinical and translational science 15 (7) (2022)
Wenyue Hu, Daniel Lettiere, Susanna Tse, Theodore R Johnson, Kathleen E Biddle, Stephane Thibault, Xavier Palazzi, Joseph Chen, Yazdi K Pithavala, Martin Finkelstein
Liver Toxicity Observed With Lorlatinib When Combined With Strong CYP3A Inducers: Evaluation of Cynomolgus Monkey as a Nonclinical Model for Assessing the Mechanism of Combinational Toxicity. Toxicological sciences : an official journal of the Society of Toxicology 182 (2) (2021)
Jerry Li, Yazdi K Pithavala, Jason Gong, Robert R LaBadie, Josué Kunjom Mfopou, Joseph Chen
The Effect of Modafinil on the Safety and Pharmacokinetics of Lorlatinib: A Phase I Study in Healthy Participants. Clinical pharmacokinetics 60 (10) (2021)
Joseph Chen, Melissa T O'Gorman, Lee P James, Karen J Klamerus, Ganesh Mugundu, Yazdi K Pithavala
Pharmacokinetics of Lorlatinib After Single and Multiple Dosing in Patients with Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer: Results from a Global Phase I/II Study. Clinical pharmacokinetics 60 (10) (2021)
Joseph Chen, Huiping Xu, Sylvester Pawlak, Leonard P James, Gerson Peltz, Kimberly Lee, Katherine Ginman, Michelle Bergeron, Yazdi K Pithavala
The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants. Advances in therapy 37 (2) (2019)

Joseph Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joseph Chen